Literature DB >> 10884394

Cross-talk between the allosteric effector-binding sites in mouse ribonucleotide reductase.

P Reichard1, R Eliasson, R Ingemarson, L Thelander.   

Abstract

We compared the allosteric regulation and effector binding properties of wild type R1 protein and R1 protein with a mutation in the "activity site" (D57N) of mouse ribonucleotide reductase. Wild type R1 had two effector-binding sites per polypeptide chain: one site (activity site) for dATP and ATP, with dATP-inhibiting and ATP-stimulating catalytic activity; and a second site (specificity site) for dATP, ATP, dTTP, and dGTP, directing substrate specificity. Binding of dATP to the specificity site had a 20-fold higher affinity than to the activity site. In all these respects, mouse R1 resembles Escherichia coli R1. Results with D57N were complicated by the instability of the protein, but two major changes were apparent. First, enzyme activity was stimulated by both dATP and ATP, suggesting that D57N no longer distinguished between the two nucleotides. Second, the two binding sites for dATP both had the same low affinity for the nucleotide, similar to that of the activity site of wild type R1. Thus the mutation in the activity site had decreased the affinity for dATP at the specificity site, demonstrating the interaction between the two sites.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884394     DOI: 10.1074/jbc.M005337200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Clofarabine 5'-di and -triphosphates inhibit human ribonucleotide reductase by altering the quaternary structure of its large subunit.

Authors:  Yimon Aye; Joanne Stubbe
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-31       Impact factor: 11.205

2.  Dynamic Control of dNTP Synthesis in Early Embryos.

Authors:  Yonghyun Song; Robert A Marmion; Junyoung O Park; Debopriyo Biswas; Joshua D Rabinowitz; Stanislav Y Shvartsman
Journal:  Dev Cell       Date:  2017-07-20       Impact factor: 12.270

3.  Diversity in Overall Activity Regulation of Ribonucleotide Reductase.

Authors:  Venkateswara Rao Jonna; Mikael Crona; Reza Rofougaran; Daniel Lundin; Samuel Johansson; Kristoffer Brännström; Britt-Marie Sjöberg; Anders Hofer
Journal:  J Biol Chem       Date:  2015-05-13       Impact factor: 5.157

4.  dNTP pool levels modulate mutator phenotypes of error-prone DNA polymerase ε variants.

Authors:  Lindsey N Williams; Lisette Marjavaara; Gary M Knowels; Eric M Schultz; Edward J Fox; Andrei Chabes; Alan J Herr
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-31       Impact factor: 11.205

5.  Cladribine and Fludarabine Nucleotides Induce Distinct Hexamers Defining a Common Mode of Reversible RNR Inhibition.

Authors:  Somsinee Wisitpitthaya; Yi Zhao; Marcus J C Long; Minxing Li; Elaine A Fletcher; William A Blessing; Robert S Weiss; Yimon Aye
Journal:  ACS Chem Biol       Date:  2016-05-20       Impact factor: 5.100

6.  AAV6-mediated Cardiac-specific Overexpression of Ribonucleotide Reductase Enhances Myocardial Contractility.

Authors:  Stephen C Kolwicz; Guy L Odom; Sarah G Nowakowski; Farid Moussavi-Harami; Xiaolan Chen; Hans Reinecke; Stephen D Hauschka; Charles E Murry; Gregory G Mahairas; Michael Regnier
Journal:  Mol Ther       Date:  2015-09-21       Impact factor: 11.454

7.  Control of dTTP pool size by anaphase promoting complex/cyclosome is essential for the maintenance of genetic stability.

Authors:  Po-Yuan Ke; Yuan-Yeh Kuo; Chuan-Mei Hu; Zee-Fen Chang
Journal:  Genes Dev       Date:  2005-08-15       Impact factor: 11.361

8.  Subcellular localization of yeast ribonucleotide reductase regulated by the DNA replication and damage checkpoint pathways.

Authors:  Ruojin Yao; Zhen Zhang; Xiuxiang An; Brigid Bucci; Deborah L Perlstein; JoAnne Stubbe; Mingxia Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

9.  Increased intracellular [dATP] enhances cardiac contraction in embryonic chick cardiomyocytes.

Authors:  Brenda Schoffstall; P Bryant Chase
Journal:  J Cell Biochem       Date:  2008-08-15       Impact factor: 4.429

10.  Modulating radiation resistance by inhibiting ribonucleotide reductase in cancers with virally or mutationally silenced p53 protein.

Authors:  Charles A Kunos; Song-mao Chiu; John Pink; Timothy J Kinsella
Journal:  Radiat Res       Date:  2009-12       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.